XML 84 R21.htm IDEA: XBRL DOCUMENT
v2.4.0.6

CAPITAL TRANSACTIONS | 12 Months Ended
--- | ---
Dec. 31, 2012
CAPITAL TRANSACTIONS |
CAPITAL TRANSACTIONS | NOTE 12: CAPITAL TRANSACTIONS Dividends The declaration of future dividends is subject to the discretion of the Company’s Board of Directors and will depend upon various factors, including the Company’s earnings, financial condition, restrictions imposed by any indebtedness that may be outstanding, cash requirements, future prospects and other factors deemed relevant by its Board of Directors. On May 7, 2012, the Company announced that its Board of Directors approved a cash dividend of $0.05 per common share in an aggregate amount of $780 that was paid on May 29, 2012 to shareholders of record on May 18, 2012. On August 1, 2012, the Company announced that its Board of Directors approved a cash dividend of $0.05 per common share in an aggregate amount of $780 that was paid on August 23, 2012 to shareholders of record on August 13, 2012. On November 2, 2012, the Company announced that its Board of Directors approved a cash dividend of $0.05 per common share in an aggregate amount of $789 that was paid on November 26, 2012 to shareholders of record on November 15, 2012. Share-Based Compensation During the year ended December 31, 2012, the Company’s shareholders adopted and approved the Nature’s Sunshine Products, Inc. 2012 Stock Incentive Plan (the “2012 Incentive Plan”). The 2012 Incentive Plan provides for the grant of incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock, restricted stock units, dividend equivalent rights, performance awards, stock awards and other stock-based awards. The Compensation Committee of the Board of Directors has authority and discretion to determine the type of award as well as the amount, terms and conditions of each award under the 2012 Incentive Plan, subject to the limitations of the 2012 Incentive Plan. A total of 1,500 shares of the Company’s common stock were authorized for the granting of awards under the 2012 Incentive Plan. The number of shares available for awards, as well as the terms of outstanding awards, are subject to adjustment as provided in the 2012 Incentive Plan for stock splits, stock dividends, recapitalizations and other similar events. The Company also maintains a stock incentive plan, which was approved by shareholders in 2009 (the “2009 Incentive Plan”). The 2009 Incentive Plan also provided for the grant of incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock, restricted stock units, dividend equivalent rights, performance awards, stock awards and other stock-based awards. Under the 2012 Incentive Plan, any shares subject to award, or awards forfeited or reacquired by the Company issued under the 2009 Incentive Plan are available for award up to a maximum of 400 shares. The Company also maintained a stock option plan, which was approved by shareholders in 1995 and expired in 2005 (“the 1995 Stock Plan”). The 1995 Stock Plan provided for the granting or awarding of certain nonqualified stock options to officers, directors and other employees. The term, not to exceed 10 years, and the vesting and exercise period of each stock option awarded under the 1995 Stock Plan were determined by the Company’s Board of Directors. Stock option activity for 2012, 2011 and 2010 consisted of the following:
|  | Number of Shares (in thousands) |  | Weighted Average Exercise Price Per Share |
Options outstanding at January 1, 2010 |  | 455 |  | $ | 8.25 |
Granted |  | 475 |  | 10.03 |
Forfeited or canceled |  | (48 | ) | 9.98 |
Exercised |  | (23 | ) | 5.81 |
Options outstanding at December 31, 2010 |  | 859 |  | 9.20 |
Granted |  | 630 |  | 10.84 |
Forfeited or canceled |  | (79 | ) | 9.64 |
Exercised |  | (36 | ) | 11.08 |
Options outstanding at December 31, 2011 |  | 1,374 |  | 9.88 |
Granted |  | 686 |  | 15.11 |
Forfeited or canceled |  | (35 | ) | 13.60 |
Exercised |  | (241 | ) | 9.95 |
Options outstanding at December 31, 2012 |  | 1,784 |  | $ | 11.81 |
The Company’s outstanding stock options include time-based stock options which vest over differing periods ranging from the date of issuance up to 48 months from the option grant date, performance-based stock options which vest upon achieving operating income margins of six, eight and ten percent as reported in four of five consecutive quarters over the term of the options, and performance-based stock options which vest upon achieving cumulative annual net sales revenue growth targets over a rolling two-year period subject to the Company maintaining at least an eight percent operating income margin during the applicable period. During the year ended December 31, 2012, the Company issued time-based options to purchase 217 shares of common stock under the 2009 Incentive Plan to the Company’s new senior executives. These options were issued with a weighted average exercise price of $15.65 per share and a weighted average grant date fair value of $7.66 per share. All of the options issued have an option termination date of ten years from the option grant date. Also, during the year ended December 31, 2012, the Company issued options to purchase 469 shares of common stock under the 2012 Incentive Plan to the Company’s executive officers and other employees, which are composed of both time-based stock options and net sales revenue performance-based stock options. These options were issued with a weighted average exercise price of $14.86 per share and a weighted average grant date fair value of $7.00 per share. All of the options issued have an option termination date of ten years from the option grant date. During the year ended December 31, 2011, the Company issued options to purchase 630 shares of common stock under the 2009 Incentive Plan to the Company’s executive officers, other employees and to new members of its Board of Directors. These options were issued with a weighted-average exercise price of $10.84 per share, and a weighted-average grant date fair value of $5.13 per share. All of the options issued have an option termination date of ten years from the option grant date. During the year ended December 31, 2010, the Company issued options to purchase 475 shares of common stock under the 2009 Incentive Plan, issued to the Company’s executive officers and other employees and to a new member of the Board of Directors, of which 300 were subject to achieving certain operating income metrics. These options were issued with a weighted average exercise price of $10.03 per share, and a weighted-average grant date fair value of $4.27 per share. All of the 475 options issued have an option termination date of ten years from the option grant date. For the years ended December 31, 2012, 2011 and 2010, the Company issued 241, 36 and 23 shares of common stock upon the exercise of stock options at an average exercise price of $9.95, $11.08 and $5.81 per share, respectively. The aggregate intrinsic values of options exercised during the years ended December 31, 2012, 2011and 2010 was $1,427, $211 and $82, respectively. For the year ended December 31, 2012, the Company recognized $378 of tax benefits from the exercise of stock options during the period. The fair value of each option grant was estimated on the date of the grant using the Black-Scholes option-pricing model with the following weighted average assumptions for the years ended December 31, 2012, 2011 and 2010:
|  | 2012 |  | 2011 |  | 2010 |
Weighted average grant date fair value of grants |  | $ | 7.21 |  | $ | 5.13 |  | $ | 4.27 |
Expected life (in years) |  | 4.0 to 6.0 |  | 3.0 to 4.0 |  | 4.0 |
Risk-free interest rate |  | 0.3 to 0.9 |  | 0.7 to 1.2 |  | 0.6 to 1.5 |
Expected volatility |  | 58.5 to 66.0 |  | 49.0 to 67.7 |  | 51.3 to 65.8 |
Dividend yield |  | 0.0 to 1.3 |  | 0.0 |  | 0.0 |
Expected option lives and volatilities are based on historical data of the Company. The risk free interest rate is calculated as the average U.S. Treasury bill rate that corresponds with the option life. Share-based compensation expense from time-based stock options for the years ended December 31, 2012, 2011 and 2010 was $2,101, $557 and $437, respectively; the related tax benefit was approximately $850, $222 and $173, respectively. As of December 31, 2012, 2011 and 2010, the unrecognized share-based compensation cost related to grants described above was $2,715, $607 and $451, respectively. As of December 31, 2012, the remaining compensation cost is expected to be recognized over the weighted-average period of approximately 1.8 years. Shared-based compensation expense from operating income performance-based stock options for the years ended December 31, 2012, 2011 and 2010 was $653, $2,921 and $0, respectively; the related tax benefit of approximately $255, $1,168 and $0, respectively. As of December 31, 2012, there is no remaining compensation expense to be recognized for the operating income performance-based stock options. The Company has not recognized any share-based compensation expense related to the net sales revenue performance-based stock options for the year ended December 31, 2012. Should the Company attain all of the net sales revenue metrics related to the net sales revenue performance-based stock option grants, the Company would recognize up to $600 of potential share-based compensation expense. The following table summarizes information about options outstanding and exercisable at December 31, 2012.
|  | Options Outstanding |  | Options Exercisable |
Range of Option Prices Per Share |  | Options Outstanding |  | Weighted-Avg. Remaining Contractual Life |  | Weighted-Avg. Exercise Price Per Share |  | Options Exercisable |  | Weighted-Avg. Remaining Contractual Life |  | Weighted-Avg. Exercise Price Per Share |
$5.35 to $9.99 |  | 740 |  | 7.5 |  | $ | 8.08 |  | 690 |  | 7.5 |  | $ | 8.05 |
$10.00 to $11.99 |  | 188 |  | 7.3 |  | 11.38 |  | 188 |  | 7.3 |  | 11.38 |
$12.00 to $16.12 |  | 856 |  | 9.0 |  | 15.12 |  | 133 |  | 8.5 |  | 15.05 |
|  | 1,784 |  | 8.2 |  | $ | 11.81 |  | 1,011 |  | 7.6 |  | $ | 9.59 |
At December 31, 2012, the aggregate intrinsic value of outstanding options to purchase 1,784 shares of common stock, the exercisable options to purchase 1,011 shares of common stock, and options to purchase 644 shares of common stock expected to vest was $5,315, $5,016 and $281, respectively. At December 31, 2011, the aggregate intrinsic value of outstanding options to purchase 1,374 shares of common stock, the exercisable options to purchase 772 shares of common stock, and options to purchase 602 shares of common stock expected to vest was $7,757, $4,819 and $2,732, respectively. During the period ended December 31, 2012, the Company issued 18 restricted stock units (RSUs) of common stock under the 2012 Incentive Plan to the Board of Directors. The RSUs were issued with a weighted average grant date fair value of $12.07 per share and vest in 12 monthly installments over a one year period from the grant date. Restricted stock unit activity for the period ended December 31, 2012 is as follows:
|  | Number of Shares |  | Weighted Average Grant Date Fair Value |
Units outstanding at December 31, 2011 |  | — |  | $ | — |
Granted |  | 18 |  | 12.07 |
Issued |  | — |  | — |
Forfeited |  | — |  | — |
Units outstanding at December 31, 2012 |  | 18 |  | 12.07 |
RSUs are valued at the market value on the date of grant. Due to post-vesting restrictions, a Finnerty Model was utilized to calculate a valuation discount from the market value of common shares reflecting the restriction embedded in the RSUs preventing the sale of the underlying shares over a certain period of time. The Finnerty Model proposes to estimate a discount for lack of marketability such as transfer restrictions by using an option pricing theory. This model has gained recognition through its ability to address the magnitude of the discount by considering the volatility of a company’s stock price and the length of restriction. The concept underpinning the Finnerty Model is that restricted stock cannot be sold over a certain period of time. Share-based compensation expense from RSUs for the period ended December 31, 2012 was approximately $124 and the related tax benefit was approximately $49. As of December 31, 2012, the unrecognized share-based compensation expense related to the grants described above was $99. As of December 30, 2012, the remaining compensation expense is expected to be recognized over the weighted average period of approximately 0.4 years.

X
- Details
Name: | natr_CapitalTransactionsDisclosureAbstract
Namespace Prefix: | natr_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Entire disclosure of dividends and share based compensation of the reporting entity. + References No definition available. + Details
Name: | natr_DividendsAndShareBasedCompensationDisclosureTextBlock
Namespace Prefix: | natr_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration